Company profile for Vericel Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects ...
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
64 Sidney Street, Cambridge, MA 02139
Telephone
Telephone
(617) 588-5555
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/14/3188310/34447/en/Vericel-to-Present-at-the-Stephens-Annual-Investment-Conference-on-Thursday-November-20-2025.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/10/23/3172034/34447/en/Vericel-to-Report-Third-Quarter-2025-Financial-Results-on-November-6-2025.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/08/28/3140782/34447/en/Vericel-to-Present-at-the-Wells-Fargo-Healthcare-Conference-on-Thursday-September-4-2025.html

GLOBENEWSWIRE
28 Aug 2025

https://www.globenewswire.com/news-release/2025/07/31/3124966/34447/en/Vericel-Reports-Second-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
31 Jul 2025

https://www.globenewswire.com/news-release/2025/07/17/3117208/34447/en/Vericel-to-Report-Second-Quarter-2025-Financial-Results-on-July-31-2025.html

GLOBENEWSWIRE
17 Jul 2025

https://www.globenewswire.com/news-release/2025/06/10/3096628/34447/en/Vericel-to-Present-at-the-Truist-Securities-MedTech-Conference-on-Tuesday-June-17-2025.html

GLOBENEWSWIRE
10 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty